Exelon Corp: Form 10-Q for the period ended Sep 30, 2021
Filed with the SEC on Nov 3, 2021 and accepted by EDGAR at Nov 3, 2021, 14:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-07-01 to 2021-09-30 | $8.91bn | us-gaap:Revenues |
| Revenue | 9 months2021-01-01 to 2021-09-30 | $26.71bn | us-gaap:Revenues |
| Operating income | 3 months2021-07-01 to 2021-09-30 | $1.86bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-09-30 | $2.10bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-07-01 to 2021-09-30 | $174.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-01-01 to 2021-09-30 | $229.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-07-01 to 2021-09-30 | $1.23bn | us-gaap:ProfitLoss |
| Net income | 9 months2021-01-01 to 2021-09-30 | $1.44bn | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2021-07-01 to 2021-09-30 | $1.23 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-01-01 to 2021-09-30 | $1.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-07-01 to 2021-09-30 | $1.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-01-01 to 2021-09-30 | $1.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-07-01 to 2021-09-30 | 980,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-01-01 to 2021-09-30 | 979,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-01-01 to 2021-09-30 | $4.14bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-07-01 to 2021-09-30 | $1.93bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 9 months2021-01-01 to 2021-09-30 | $5.97bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2021-01-01 to 2021-09-30 | $1.12bn | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2021-09-30 | $2.96bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-09-30 | $14.88bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $132.62bn | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $15.83bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-09-30 | $98.36bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-09-30 | $35.27bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2021-09-30 | $2.67bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2021-09-30 | $33.85bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2021-09-30 | 978,317,787 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001109357-21-000110. Last ingested by Listed: Nov 14, 2026, 14:06 ET. Listed shows no prices and gives no investment advice.